18VAC85-21-90: Informed consent and agreement for treatment for chronic pain
Where this section sits in the code
- Title 18. Professional And Occupational Licensing
- Agency 85. Board of Medicine
- Chapter 21. Regulations Governing Prescribing of Opioids and Buprenorphine
- Part III. Management of Chronic Pain
A. The practitioner shall document in the medical record informed consent, to include risks, benefits, and alternative approaches, prior to the initiation of opioids for chronic pain.
B. There shall be a written treatment agreement signed by the patient in the medical record that addresses the parameters of treatment, including those behaviors that will result in referral to a higher level of care, cessation of treatment, or dismissal from care.
C. The treatment agreement shall include notice that the practitioner will query and receive reports from the Prescription Monitoring Program and permission for the practitioner to:
1. Obtain urine drug screens or serum medication levels when requested; and
2. Consult with other prescribers or dispensing pharmacists for the patient.
D. Expected outcomes shall be documented in the medical record including improvement in pain relief and function or simply in pain relief. Limitations and side effects of chronic opioid therapy shall be documented in the medical record.
Collected 2026-09-14T04:52:45Z. Source file · JSON